TITLE

New drugs and dosage forms

PUB. DATE
December 2010
SOURCE
American Journal of Health-System Pharmacy;12/15/2010, Vol. 67 Issue 24, p2080
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides information on several drugs and their dosage forms which include acetaminophen injection, ceftaroline fosamil injection, and dextromethorphan hydrobromide and quinidine sulfate capsules.
ACCESSION #
56584741

 

Related Articles

  • JOURNAL CLUB. METFORMIN COMBO BEST FOR MAINTAINING GLYCEMIC CONTROL IN TYPE 2 DIABETES. Burke, Michael // Contemporary Pediatrics;Jul2012, Vol. 29 Issue 7, p11 

    The article discusses a study comparing 3 treatments for type 2 diabetes, metformin monotherapy, metformin plus rosiglitazone and metformin plus a lifestyle intervention program in children between the ages of 10-17 years across ethnic groups. The article includes comments by Michael Burke...

  • IV treatment for bacterial infections.  // Clinical Advisor;Feb2011, Vol. 14 Issue 2, p29 

    The article offers brief information on Teflaro from Forest Laboratories Inc.

  • New treatment for type 2 diabetes.  // Clinical Advisor;Mar2011, Vol. 14 Issue 3, p34 

    The article offers brief information on the Kombiglyze XR 5/500, the new treatment for type 2 diabetes, from Bristol-Myers Squibb Co.

  • A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy. White, Judith L.; Buchanan, Patricia; Jia Li; Frederich, Robert // BMC Endocrine Disorders;2014, Vol. 14 Issue 1, p1 

    Background To compare the safety and efficacy of saxagliptin 2.5 mg twice daily (BID) versus placebo add-on therapy to metformin immediate release (IR) in patients with type 2 diabetes and inadequate glycemic control with metformin alone. Methods This multicenter, 12-week, double-blind,...

  • Special Considerations with Insulin Therapy in Older Adults with Diabetes Mellitus. Mooradian, Arshag D. // Drugs & Aging;2011, Vol. 28 Issue 6, p429 

    Aging is associated with alterations in insulin secretion and action. How- ever, aging per se does not alter the pharmacokinetics of commercially available insulin and its analogues. Insulin therapy in older adults is complicated by psychosocial and physiological changes of aging. Several new...

  • Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes. Richard III, John W.; Raskin, Philip // Clinical Medicine Insights: Endocrinology & Diabetes;2011, Issue 4, p29 

    As the prevalence of type 2 diabetes continues to rise, new drug therapies will need to be explored to prevent morbidity and mortality associated with diabetes as well as growing health care costs. Type 2 diabetes is characterized by decreased insulin secretion and sensitivity. Numerous oral...

  • Industry update.  // Diabetes Digest;2014, Vol. 13 Issue 4, p198 

    The article offers news briefs related to diabetes management as of December 2014. Topics covered include the approval received by Novo Nordisk for IDegLira or Xultophy, its once-daily combination of insulin degludec and liraglutide, in Europe, and the Conformité Européenne (CE) mark...

  • Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials. Grunberger, George // European Journal of Clinical Pharmacology;Nov2014, Vol. 70 Issue 11, p1277 

    Purpose: To review efficacy and safety data of dipeptidyl peptidase-4 inhibitors used in treatment of patients with type 2 diabetes mellitus. Methods: A search of MEDLINE®/PubMed®, a service of the National Library of Medicine of the National Institutes of Health as well as of the original...

  • FDA Drug Approvals. New combination.  // Formulary;Jan2011, Vol. 46 Issue 1, p4 

    The article reports on research which the U.S. Food and Drug Administration conducted on the efficacy, safety and proper dosage of the combination drug Kombiglyze XR, which contains the drugs Saxagliptin and metformin and is used to improve glycemic control in type two diabetics. Approval which...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics